MOSAIC IMMUNOENGINEERING, INC. Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31)
MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) of $898.63 thousand for the 3-month period ending 2015-02-28, per its 10-Q filed 2015-04-14.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss · last filed 2015-04-14
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2015-02-28 was $898.63K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2014-11-30 was -$159.28K, a 111.80% decline year-over-year.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2014-02-28 was -$59.78K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2013-11-30 was $1.35M.
| Period end | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 9 month |
|---|---|---|---|
| 2015-02-28 | $898.63K 10-Q · filed 2015-04-14 | $739.34K derived: sum of 2 quarters · filed 2015-04-14 | $291.27K 10-Q · filed 2015-04-14 |
| 2014-11-30 | -$159.28K 10-Q · filed 2015-01-14 | -$607.36K 10-Q · filed 2015-01-14 | |
| 2014-02-28 | -$59.78K 10-Q · filed 2015-04-14 | $1.29M derived: sum of 2 quarters · filed 2015-04-14 | $1.12M 10-Q · filed 2015-04-14 |
| 2013-11-30 | $1.35M 10-Q · filed 2015-01-14 | $1.18M 10-Q · filed 2015-01-14 |